• Wed news: Lilly’s 4.5B medicine foundry project. 5 FDA decisions to watch in Q4. Hurricane Helene and the health supply chain. Lundbeck taps Charles River for AI-enabled neuro drug discovery. Amgen tax evasion lawsuit. See more on our front page

Humira goes off patent next year

















When Humira goes off patent, what will Abbvie have to replace all of that lost revenue? I imagine that there must be a plan in place to adjust operating costs accordingly.
 




















Amgen announced a Phase 3 study evaluating the efficacy and safety of biosimilar candidate ABP 501 compared with Humira® (adalimumab) in patients with moderate-to-severe rheumatoid arthritis met its primary and key secondary endpoints.


Why didn't they come out with Humira XR or something to keep us employed longer?
 




































Degree less, liar, Rickey does not care. Down goes Abbvie, he gets his package and has lots of money. Maybe when he retires he will finish school.

They are all assholes.
 








Similar threads

Replies
10
Views
4K
AbbVie
anonymous
Replies
10
Views
4K
AbbVie
anonymous
Replies
30
Views
7K
AbbVie
anonymous